Advanced Magnetics at buy by Jefferies

Jefferies & Co., Inc. analyst Adam Walsh rated Advanced Magnetics, Inc. at a buy following additional checks with investigators in the ongoing ferumoxytol P3 trials. The analyst has increased confidence in the drug's safety profile and prospects for approval. Shares of the Cambridge, Mass.-based pharmaceutical products company were down 11 cents, or 0.34%, at $32.19, on volume of 135,399 shares versus the three-month running average of 3,120,440 shares. (Nasdaq: AMAG)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.